Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals board to consider financial statements

19 Oct 2012 Evaluate
Glenmark Pharmaceuticals has informed that a meeting of the board of directors will be held on October 30, 2012, to consider and approve the company’s un-audited financial statements for the second quarter/half year ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..